Certified by Founder Lodge
Alzheimer's Drug Discovery Foundation
United States - New York, NY
INVESTOR
1 Disclosed Funding Rounds $73,000,000
5 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Conquering Alzheimer’s Through Drug Discovery.
Founded in 1998 by Leonard A. Lauder and Ronald S. Lauder, the Alzheimer’s Drug Discovery Foundation (ADDF) was one of the first charities to
| Company | Date | Round | Raised |
|---|---|---|---|
 Cognito Therapeutics, Inc. |
March, 23 ,2023 | Series B | $73,000,000 |
 Therini Bio, Inc. |
April, 27 ,2023 | Series A | $36,000,000 |
 ALZpath Inc. |
July, 19 ,2023 | Unknown | |
 Astrocyte Pharmaceuticals |
August, 22 ,2023 | Pre-Series B | $6,000,000 |
 CuraSen Therapeutics, Inc. |
October, 17 ,2023 | Unknown | $5,800,000 |
Knit
CHARM Therapeutics
Curebase
SLAMcore Limited
Anthropic
Katalist | $1,500,000 | (Dec 19, 2025)
Amphix Bio | $12,500,000 | (Dec 19, 2025)
Neural Concept | $100,000,000 | (Dec 19, 2025)
Gravity Labs Co., Ltd. | $17,000,000 | (Dec 19, 2025)
arcads AI | $16,000,000 | (Dec 19, 2025)
